Neogen Chemicals Limited (NEOGEN) Earnings Call Transcripts

Neogen Chemicals Limited's Latest Earnings Call - Q4 FY2026

In Q4 FY '26, Neogen Chemicals Limited reported revenue of INR 247 crores, a 22% year-on-year increase, while EBITDA rose 21% to INR 44 crores, maintaining an EBITDA margin of 17.8%. The company signaled strong demand visibility across its core products, particularly in the battery materials segment, which is expected to drive future growth. Management provided guidance for FY '27, projecting revenues between INR 875 crores and INR 950 crores, reflecting a slight downward revision due to delays in the commissioning of the Dahej facility.

Reported metrics

Guidance from management

Management anticipates FY '27 revenues in the range of INR 875 crores to INR 950 crores, reflecting a cautious outlook due to delays in project timelines. They remain committed to achieving higher revenue through organo lithium and lithium compounds.

What management said

Okay. Yes, yes, sorry. So absolute increase in inventory was mainly driven because we had taken some of the outside locations on kind of rent basis to basically get capacities. So these contracts were getting over by month of March. And since Dahej was not fully yet online, we kind of build up some inventories to take care of our sales like in Q1 and Q2 level. We also decided to ultimately decide to extend it slightl...

And just for clarification. Like whatever interest is during the project is already considered in the revised cost of the project. So until the time it is capitalized, the interest is already included in the revised cost.

What analysts pressed on

Analysts expressed concerns over the delay in the Dahej facility's commissioning and its impact on revenue guidance. There were also questions regarding the sustainability of current lithium prices and their effect on future profitability.

Main topics on the call

• Revenue Growth — Neogen Chemicals achieved a revenue of INR 247 crores in Q4 FY '26, up 22% year-on-year, driven by high client utilization and improved volumes across key applications. Management noted, "Our growth momentum was supporte...
• Battery Materials Strategy — The company emphasized its strategic shift towards battery materials, with plans for commercial manufacturing of electrolyte targeted for H1 FY '27. Management stated, "Neogen Ionics is well positioned to emerge as a glo...
• Guidance Revision — Management revised FY '27 revenue guidance to INR 875 crores to INR 950 crores, down from earlier expectations due to delays in the Dahej facility. They indicated, "We are trying our best with organo lithium and lithium ...
• Operational Challenges — The company faced elevated input costs and supply chain disruptions, impacting profitability. Despite this, management maintained that their strategic pass-through mechanism helped protect core profitability.

Read the full Neogen Chemicals Limited transcript (Q4 FY2026) → Summary generated from the call transcript; every figure above is stated by management on the record.

Earnings Call History

EarningsCalls.dev has 19 Neogen Chemicals Limited earnings call transcripts on record, spanning August 9, 2021 to July 27, 2026. Based on this history, Neogen Chemicals Limited reports quarterly. The most recent call on file is dated July 27, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker

NEOGEN

Exchange

NSEI

Country

IN

Sector

Materials

Industry

Chemicals

Calls on record

19

First call

August 9, 2021

Most recent

July 27, 2026

Reporting cadence

quarterly